Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2008 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Microbiology |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822008000400025 |
Resumo: | Itraconazole is currently considered the drug of choice to treat the diverse clinical presentation of sporotrichosis. On the other hand terbinafine by virtue of its excellent in vitro activity is under comparative evaluation for its therapeutic potential for a wide range of fungal infections. In this study, our aim was to determine the in vivo efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis. 120 rats Wistar received an injection of 2x10³ S. schenckii cells by via the lateral tail vein. After 3 days the animals were treated with terbinafine (250mg/kg) and itraconazole (100 mg/kg) and their respective diluents. In our model, terbinafine and itraconazole were effective in reducing the number of clinical lesions and positive organ cultures. There was statistical difference between the groups treated with the antifungals in relation to the control groups (p<0,05) concerning the clinical alterations, anatomic-pathological findings and in the positive organ cultures of the agent, being that the treated animals resulted in the absence and/or reduction of all the evaluated parameters. As for the treatments, terbinafine showed similar or higher activity that itraconazole in the evaluation of the testicle alteration (p=0,0004), as well as in the positive organ cultures of microorganism from the organ (p=0,0142). With these results it is possible to conclude that the antifungals studied are effective in the treatment of experimental systemic sporotrichosis. |
id |
SBM-1_4d13c8c428e3bfb7f9b9f4aa40a41019 |
---|---|
oai_identifier_str |
oai:scielo:S1517-83822008000400025 |
network_acronym_str |
SBM-1 |
network_name_str |
Brazilian Journal of Microbiology |
repository_id_str |
|
spelling |
Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosisitraconazoleterbinafinesporotrichosisantifungalItraconazole is currently considered the drug of choice to treat the diverse clinical presentation of sporotrichosis. On the other hand terbinafine by virtue of its excellent in vitro activity is under comparative evaluation for its therapeutic potential for a wide range of fungal infections. In this study, our aim was to determine the in vivo efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis. 120 rats Wistar received an injection of 2x10³ S. schenckii cells by via the lateral tail vein. After 3 days the animals were treated with terbinafine (250mg/kg) and itraconazole (100 mg/kg) and their respective diluents. In our model, terbinafine and itraconazole were effective in reducing the number of clinical lesions and positive organ cultures. There was statistical difference between the groups treated with the antifungals in relation to the control groups (p<0,05) concerning the clinical alterations, anatomic-pathological findings and in the positive organ cultures of the agent, being that the treated animals resulted in the absence and/or reduction of all the evaluated parameters. As for the treatments, terbinafine showed similar or higher activity that itraconazole in the evaluation of the testicle alteration (p=0,0004), as well as in the positive organ cultures of microorganism from the organ (p=0,0142). With these results it is possible to conclude that the antifungals studied are effective in the treatment of experimental systemic sporotrichosis.Sociedade Brasileira de Microbiologia2008-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822008000400025Brazilian Journal of Microbiology v.39 n.4 2008reponame:Brazilian Journal of Microbiologyinstname:Sociedade Brasileira de Microbiologia (SBM)instacron:SBM10.1590/S1517-83822008000400025info:eu-repo/semantics/openAccessMeinerz,Ana Raquel ManoXavier,Melissa O.Cleff,Marlete BrumMadrid,Isabel MartinsNobre,Márcia OliveiraMeireles,Mário Carlos AraújoMello,João Roberto Braga deeng2009-04-06T00:00:00Zoai:scielo:S1517-83822008000400025Revistahttps://www.scielo.br/j/bjm/ONGhttps://old.scielo.br/oai/scielo-oai.phpbjm@sbmicrobiologia.org.br||mbmartin@usp.br1678-44051517-8382opendoar:2009-04-06T00:00Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM)false |
dc.title.none.fl_str_mv |
Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis |
title |
Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis |
spellingShingle |
Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis Meinerz,Ana Raquel Mano itraconazole terbinafine sporotrichosis antifungal |
title_short |
Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis |
title_full |
Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis |
title_fullStr |
Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis |
title_full_unstemmed |
Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis |
title_sort |
Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis |
author |
Meinerz,Ana Raquel Mano |
author_facet |
Meinerz,Ana Raquel Mano Xavier,Melissa O. Cleff,Marlete Brum Madrid,Isabel Martins Nobre,Márcia Oliveira Meireles,Mário Carlos Araújo Mello,João Roberto Braga de |
author_role |
author |
author2 |
Xavier,Melissa O. Cleff,Marlete Brum Madrid,Isabel Martins Nobre,Márcia Oliveira Meireles,Mário Carlos Araújo Mello,João Roberto Braga de |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Meinerz,Ana Raquel Mano Xavier,Melissa O. Cleff,Marlete Brum Madrid,Isabel Martins Nobre,Márcia Oliveira Meireles,Mário Carlos Araújo Mello,João Roberto Braga de |
dc.subject.por.fl_str_mv |
itraconazole terbinafine sporotrichosis antifungal |
topic |
itraconazole terbinafine sporotrichosis antifungal |
description |
Itraconazole is currently considered the drug of choice to treat the diverse clinical presentation of sporotrichosis. On the other hand terbinafine by virtue of its excellent in vitro activity is under comparative evaluation for its therapeutic potential for a wide range of fungal infections. In this study, our aim was to determine the in vivo efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis. 120 rats Wistar received an injection of 2x10³ S. schenckii cells by via the lateral tail vein. After 3 days the animals were treated with terbinafine (250mg/kg) and itraconazole (100 mg/kg) and their respective diluents. In our model, terbinafine and itraconazole were effective in reducing the number of clinical lesions and positive organ cultures. There was statistical difference between the groups treated with the antifungals in relation to the control groups (p<0,05) concerning the clinical alterations, anatomic-pathological findings and in the positive organ cultures of the agent, being that the treated animals resulted in the absence and/or reduction of all the evaluated parameters. As for the treatments, terbinafine showed similar or higher activity that itraconazole in the evaluation of the testicle alteration (p=0,0004), as well as in the positive organ cultures of microorganism from the organ (p=0,0142). With these results it is possible to conclude that the antifungals studied are effective in the treatment of experimental systemic sporotrichosis. |
publishDate |
2008 |
dc.date.none.fl_str_mv |
2008-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822008000400025 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822008000400025 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S1517-83822008000400025 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Microbiologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Microbiologia |
dc.source.none.fl_str_mv |
Brazilian Journal of Microbiology v.39 n.4 2008 reponame:Brazilian Journal of Microbiology instname:Sociedade Brasileira de Microbiologia (SBM) instacron:SBM |
instname_str |
Sociedade Brasileira de Microbiologia (SBM) |
instacron_str |
SBM |
institution |
SBM |
reponame_str |
Brazilian Journal of Microbiology |
collection |
Brazilian Journal of Microbiology |
repository.name.fl_str_mv |
Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM) |
repository.mail.fl_str_mv |
bjm@sbmicrobiologia.org.br||mbmartin@usp.br |
_version_ |
1752122202175569920 |